Clinical Trials in Houston

Showing 11081-11100 of 15,366 trials

Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma

NCT02225496

Standard-of-care treatment options for oropharyngeal cancer often result in long-term side effects that interfere with normal quality of life. A minimally-invasive transoral robotic surgery (TORS) approach has been developed to operate on the disease site while affecting the surrounding tissue as little as possible. Researchers think that this approach may help to control the disease and avoid such long-term side effects. The goal of this clinical research study is to learn if minimally-invasive transoral robotic surgery (TORS) can help to control HPV-positive oropharyngeal cancer. Transoral means through the mouth. The TORS approach is called the Intuitive Surgical da Vinci Surgical System. Researchers also want to learn if this surgery affects participants' ability to speak and swallow.

Oropharyngeal Cancer

M.D. Anderson Cancer Center1 participantsStarted Sep 2014

Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins

NCT02135029

This study is a multicenter, double blinded, active and placebo controlled randomized clinical trial to demonstrate a superior lipid lowering effect of Bococizumab (PF-04950615; RN316) compared to placebo in subjects who are statin intolerant.

Hyperlipidemia

Pfizer184 participantsStarted Jun 2014

Denver, Colorado, United States • Bridgeport, Connecticut, United States • Lakeland, Florida, United States +37 more locations

Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins

Find Trials by Condition in Houston

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer

Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation

Safety and Efficacy Trial of Testosterone Undecanoate

Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

Bevacizumab and Temsirolimus in Patients With Advanced Malignancy

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis

A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease

Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II

Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers

Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)

A Study of Vemurafenib in Participants With Metastatic Melanoma

Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer

Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes